Beam Therapeutics advances base-editing pipeline with risto-cel studies and FDA designations, but no approved products and rising competition loom.

On the final trading day of 2025, Cathie Wood put an eye-brow raising $1.33 million to work in Intellia Therapeutics ( NTLA ) ...

Blockchain, nanomedicine, and 3D printing signal a growing emphasis on improving healthcare delivery through innovative ...

In one of the rockiest years yet for science, Philadelphia-area researchers still managed to celebrate many wins. Here are five of them.

After years of research, scientists in China have created a bone-free fish, which has been named 'Zhongke No. 6'. The new ...

Prime Medicine Inc. (NASDAQ:PRME) is one of the best biotech penny stocks to buy according to analysts. On December 23, LifeSci Capital initiated coverage of Prime Medicine with an Outperform rating ...

Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...

Two genetic innovations could address major welfare and productivity issues within the broiler and layer industries.

Matthew Herper covers medical innovation — both its promise and its perils. It has been a tough year for medicine. The U.S.

Prime Medicine, Inc. (NASDAQ:PRME) is among the 12 Best Genomics Stocks to Invest In. Prime Medicine, Inc. (NASDAQ:PRME) ...

As the year draws to a close, we take a look at some of the biggest science stories of the year, and why they matter.

Researchers call the development a "game-changer" for aquaculture, signalling how precision genetics may increasingly ...